Search for: "Sanofi US Corporation" Results 1 - 20 of 103
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
14 Apr 2024, 9:05 pm by renholding
In Panuwat, the defendant was an employee of Medivation, Inc., a mid-cap oncology firm that was resisting one hostile bidder (Sanofi S.A.) and encouraging another firm (Pfizer) to outbid Sanofi. [read post]
23 Jan 2024, 9:01 pm by renholding
Cardinal Health The $109 million settlement with Cardinal Health resolves allegations concerning the acquisition and integration of Cordis Corporation from Johnson & Johnson for $1.9 billion in 2015. [read post]
21 Jan 2024, 9:01 pm by renholding
The Merger Guidelines note that analytical or surveillance tools used to track or predict competitor prices or actions, such as pricing algorithms, may increase market observability and, in turn, make a market more susceptible to coordination. [read post]
14 Dec 2023, 10:00 pm by Chijioke Okorie
August: In Nigeria, the French multinational pharmaceutical and healthcare company Sanofi S.A., filed a petition with the Corporate Affairs Commission (CAC) in 2019, alleging that the registration of Sanofi Integrated Services Limited, Sanofi Nigeria Enterprises Limited, and Sanofi Nigerian Enterprise was unlawful. [read post]
7 Dec 2023, 11:17 am by Seeger Weiss
This appointment positions Buchanan at the forefront of a critical legal battle against insulin manufacturers Eli Lilly, Novo Nordisk, and Sanofi – who control nearly the entire U.S. insulin market – as well as the nation’s three largest pharmacy benefit managers (PBMs), CVS Caremark, Express Scripts, and OptumRx, over allegations these companies used unlawful, unfair, and deceptive practices to aggressively hike the cost of insulin and other diabetes medications.… [read post]
2 Nov 2022, 11:43 am by John Elwood
Sanofi, a case arising from Amgen’s efforts to patent antibodies that lower cholesterol levels. [read post]
26 Oct 2022, 3:17 am by Cari Rincker
When an advertisement makes claims about a product or service, that claim may be crucial to a consumer’s decision to buy or use that product or service. [read post]
19 Jul 2022, 2:59 pm by Kevin LaCroix
  Finally, we describe and analyze the real driving forces behind these decisions, and we explain how biotech companies, their attorneys, and insurers can use these insights to greatest advantage. [read post]
21 Apr 2022, 10:07 am by Dennis Crouch
Procedure: Prior art in Inter Partes Review: Baxter Corporation Englewood v. [read post]
24 Feb 2022, 6:12 pm by Dennis Crouch
  One more is still pending – Intel Corporation v. [read post]
16 Jul 2021, 11:59 am by Kristi Wolff and Jaclyn Metzinger
Lidocaine:  One new class action was filed against Sanofi US Corp. alleging that its aspercreme patches are deceptively marketed as providing “fast acting” and “max strength” pain relief when other patch products deliver more lidocaine to the affected areas, are more effective, and are approved by FDA for more purposes. [read post]
9 Jun 2021, 12:51 pm by Matthew Marin
This leads us into our update today for those following the litigation against Sanofi, the producer of the popular Zantac drug mainly used for heartburn and GERDS. [read post]
7 May 2021, 12:09 pm by luiza
The Department of Justice announced this week that Incyte Corporation, a Delaware pharmaceutical company, has agreed to pay $12.6 million to resolve allegations that it violated the False Claims Act by paying kickbacks to a charitable foundation to increase prescriptions for the drug Jakafi, which is used to treat myelofibrosis, a form of leukemia that causes extensive scarring in bone marrow and leads to severe anemia and fatigue. [read post]
6 May 2021, 3:02 am by Greg Lambert and Marlene Gebauer
And Jack Thompson, Assistant Director of Global eDiscovery and Legal Operations at Sanofi, who, by the way, is not a lawyer, said that he prefers to see substance or quality of work, not the credentials or degrees of an individual providing expertise and knowledge. [read post]
5 Jan 2021, 12:28 pm by luiza
The Boston US Attorney’s office has collected nearly a billion dollars pursuing cases with a similar theory against many giants in the industry including Pfizer, United Therapeutics, Amgen, Astellas, Alexion, Actelion, Jazz, and Sanofi-Aventis and is currently pursuing a similar case against Regeneron. [read post]